← FDA Drug Approvals (Drugs@FDA)
LANSOPRAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-03-28
Drug application
- FDA Application #
ANDA207167- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LANSOPRAZOLE
- Generic name
- LANSOPRAZOLE
- Active ingredients
- LANSOPRAZOLE
- Dosage form
- TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- NorthStar Rx LLC
- First approval
- 2023-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown